期刊文献+

新型聚乳酸与纳米羟基磷灰石复合人工骨的性能测试研究 被引量:6

The study of a new artificial bone consisted with polylactic acid and nano-hydroxyapatite
下载PDF
导出
摘要 目的通过原位聚合法制备新型的聚乳酸与纳米羟基磷灰石复合材料,找到两者复合的最佳配比,从而得到理想的人工骨移植材料。方法采用原位聚合法按一定的配比(纳米羟基磷灰石质量分数分别为0,10%,20%,30%,40%)聚乳酸与纳米羟基磷灰石复合人工骨,对这类新型的人工骨进行性能测试,通过抗弯,抗压,弹性模量,电镜扫描,体外降解实验,观测该人工骨的力学性能、微观结构、纳米羟基磷灰石在聚乳酸中的分散情况以及复合材料的降解性能。结果 (1)力学测试显示:随着n-HA含量的增加,复合材料的拉伸强度逐渐减少。复合材料的弯曲强度在n-HA微粒的质量分数为20%时弯曲强度出现峰值(156.8 MPa)。复合材料的弯曲模量随着n-HA微粒质量分数的增加而增大。(2)SEM扫描显示:纯PDLLA材料断裂表面较平整;在n-HA含量为10%时出现大量的韧窝,明显的粗糙断裂面;在n-HA含量为20%断裂表面凹凸不平,形成大量的韧窝;在n-HA含量为30%以上时断口又变得越来越平整,尚有许多小的韧窝。(3)体外降解实验显示:随着降解时间的延长,降解液的pH值均逐渐降低,复合材料的力学性能也逐渐的产生一定的衰减。结论当n-HA含量为20%时,该人工骨复合材料有着更好的力学性能和降解性能,筛选出该种新型人工骨的最佳配比,制备出性能良好的PDLLA/n-HA复合人工骨材料。 Objective To prepare a new artificial bone material by in situ polymerization ofpolylactic acid and nano-hydroxyapatite. Methods According to a specified ratio (the mass fraction of nano-hydroxyapatite respectively was 0, 10%, 20%, 30%, and 40%), polylactic acid and nano-hydroxyapatite were composed by in situ polymerization, followed by the testing of material parameters, including mechanical, ultrastructural, dispersional features in vitro. The degradation rate of composite material was detected. Results With the increase of n-HA content, the tensile strength of composite material decreased, but the elastic modulus increased. 20% of nano-hydroxyapatite content, made the best bending strength of composite material (156.8 MPa). SEM scan showed that, the fracture surface of pure PDLLA was relatively smooth; 10% of nano-hydroxyapatite content induced obvious dimples on the fracture surface. 20% nano-hydroxyapatite content induced uneven fracture surface, with a large number of dimples. However, 30% of nano-hydroxyapatite content made the fracture surface more fiat. PH values of degradation liquid gradually reduced, as well the mechanical strength, following the extension of degradation. Conclusions Artificial bone material with 20% nano-hydroxyapatite content is ideal for its better mechanical properties and degradation properties.
出处 《中国临床解剖学杂志》 CSCD 北大核心 2012年第3期324-328,共5页 Chinese Journal of Clinical Anatomy
基金 广东省科技计划项目(83110)
关键词 聚乳酸 纳米羟基磷灰石 人工骨 Polylactic acid Nano-hydroxyapatite Artificial bone
  • 相关文献

参考文献10

  • 1Jayasuriya AC, Shah C, Ebraheim NA, et al. Acceleration of biomimetic mineralization to apply in bone regeneration [J]. Biomed Mater, 2008,3 (1):015003.
  • 2Ren J,Zhao P,Ren T, et al. Poly (D,L-lactide)/nano-hydroxyapatite composite scaffolds for bone tissue engineering and biocompatibility evaluation[J]. J Mater Sci Mater Med, 2008,19(3): 1075 - 1082.
  • 3Neuendorf RE, Saiz E, Tomsia AP, et al. Adhesion between biodegradable polymers and hydroxyaptite: relevance to synthetic bone-1 ike materials and tissue engineering scaffolds [J]. Acta Biomater, 2008, 4(5):1288-1296.
  • 4Shen L, Yang H, Ying J, et al. Preparation and mechanical properties of carbon fiber reinforced hydroxyapatite/polylactide biocomposites [J]. J Mater Sci Mater Med,2009, 20(11):2259-2265.
  • 5孙雪,奚廷斐.生物材料和再生医学的进展[J].中国修复重建外科杂志,2006,20(2):189-193. 被引量:29
  • 6顾汉卿.生物医学材料的现状及发展(一)[J].中国医疗器械信息,2001,7(1):45-48. 被引量:5
  • 7Holland S J, Tighe B J, Gould PL. Polymers for biodegradable medical devices. I: The potential of polyesters as controlled macromoleeular release systems[J]. Journal of Controlled Release, 1986, 4(3): 155-180.
  • 8Degee P, Dubois P, Jacobsen S, et al. Beneficial effect of triphenylphosphine on the bulk polymerization of L, L-lactide promoted by 2-ethylbexanoic acid tin (II) salt[J]. Journal of Polymer Science Part A Polymer Chemistry, 1999, 37(14): 2413-2420.
  • 9郭晓东,郑启新,杜靖远,全大萍,闫玉华,李世普,李香亮.可吸收羟基磷灰石/聚DL-乳酸骨折内固定材料机械强度和生物降解性研究[J].中国生物医学工程学报,2001,20(1):23-27. 被引量:51
  • 10滕新荣,顾书英,任杰.超临界CO_2中制备聚乳酸/羟基磷灰石复合支架材料[J].材料导报,2005,19(9):114-117. 被引量:6

二级参考文献33

  • 1Xu Qun,Ren Xian-wen,Chang Yu-ning,Yu Long,Wang Jing-wu.Generation of Microcellular Biodegradable Polycaprolactone Foams in Supercritical Carbon Dioxide[J].合成化学,2004,12(z1):113-113. 被引量:5
  • 2徐又佳,郑祖根,王晓东,董启榕,沈忆新,成茂华,蔡丽君.可吸收固定材料对实验性骨折愈合影响的超微结构观察[J].中华骨科杂志,1996,16(10):653-655. 被引量:29
  • 3Vacanti JP, Langer R, Upton J, et al. Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev, 1998,33 (1-2) :165-182.
  • 4Hubbell JA,Massia SP,Desai NP,et al. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor, Biotechnology, 1991,9(6) :568-572.
  • 5Hunter DD,Cashman N ,Morris-Valero R oet al. An LRE (leucine-arginine-glutamate)-dependent mechanism for adhesion of neurons to S-laminin. J Neurosci, 199l, 11 (12) t 3960-3971,.
  • 6Patel N, Padera R.Sanders GH, et al. Spatially controlled cell engineering on biodegradable polymer surfaces. FASEB J,1998,12(14) : 1447-1454.
  • 7Mahoney MJ, Saltzman WM, Transplantation of brain cells assembled around a programmable synthetic microenvironment.Nat Biotechno1,2001,19 (10): 934-939.
  • 8Hench LL. Bioactive materials: the potential for tissue regeneration. J Biomed Mater Res, 1998,41 ( 4 ) : 511- 518.
  • 9Yamamuro T, Hench LL, Wilson J, Eds, CRC Handbook of Bioactive Ceramics,Vol 2,Calcium Phosphate and Hydroxylapatite Ceramics ,Boca Raton : CRC Press, 1990,373-377.
  • 10Hench LL, Wilson J, Eds, An Introduction to Bioceramics.London : World Scientific, 1993,199-221.

共引文献87

同被引文献78

  • 1张阳德,乐园,赵梓屹.羟基磷灰石骨修复材料[J].中国现代医学杂志,2006,16(1):72-75. 被引量:16
  • 2罗庆平,刘桂香,杨世源,尹光福,郑昌琼.磷酸单酯偶联剂改性羟基磷灰石/高密度聚乙烯复合人工骨材料的制备和性能[J].复合材料学报,2006,23(1):80-84. 被引量:13
  • 3黄永辉,沈铁城,徐晓峰,左华,韩志强,田进.纳米羟基磷灰石/胶原骨修复骨缺损的效果评估[J].中国临床康复,2006,10(37):51-53. 被引量:19
  • 4黄福龙,戴红莲,方园,单学智,李世普.HA/PDLLA复合材料的制备及其降解性能研究[J].无机材料学报,2007,22(2):333-338. 被引量:14
  • 5Milla LA,Simpson AH.In vivo models of bone repair.J Bone Joint Surg Br.2012;94(7):865-874.
  • 6Kolk A,Handschel J,Drescher W,et aI,Current trends and future perspectives of bone substitute materials: from space holders to innovative biomaterials.J Craniomaxillofac Surg. 2012;40(8):706-718.
  • 7Bohner M.Design of ceramic-based cements and putties for bone fraft substitution.Eur Cell Mater.2010;20:1-12.
  • 8Hao W,Dong J,Etal JM,et aI.Enhanced bone formation in large segmental radial defects by combining adipose- derived stem cells expressing bone morphogenetic protein 2 with nHA/RHLC/PLA scaffold.lnt Orthop.2010;34(8): 1341-1349.
  • 9Corrigan OI,Li X.Quantifying drug release from PLGA nanoparticulates. Eur JPharmSci.2009;37(3):477-485.
  • 10Lee JH,Rim NG, Jung HS,et aI.Control of osteogenic differentiation and mineralization of human mesenchymal stem cells on composite nanfibers containing poly lactic-co-(glycolic acid) and hudroxyapatite.Macromol Biosci. 2010; 10(2): 173-182.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部